Surmodics Market Cap

Surmodics has a market cap or net worth of $408.67 million as of June 27, 2025. Its market cap has decreased by -31.53% in one year.

Market Cap

408.67M

Enterprise Value

410.33M

1-Year Change

-31.53%

Ranking

#3095

Market Cap Chart

Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $408.67M, an increase of 505.44%. That is a compound annual growth rate of 7.01%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	416.00M	-26.67%
Dec 31, 2024	567.30M	10.24%
Dec 29, 2023	514.60M	7.43%
Dec 30, 2022	479.00M	-28.45%
Dec 31, 2021	669.50M	12.48%
Dec 31, 2020	595.20M	6.04%
Dec 31, 2019	561.30M	-11.36%
Dec 31, 2018	633.20M	72.63%
Dec 29, 2017	366.80M	9.33%
Dec 30, 2016	335.50M	27.86%
Dec 31, 2015	262.40M	-7.67%
Dec 31, 2014	284.20M	-15.16%
Dec 31, 2013	335.00M	2.20%
Dec 31, 2012	327.80M	27.55%
Dec 30, 2011	257.00M	23.97%
Dec 31, 2010	207.30M	-47.64%
Dec 31, 2009	395.90M	-11.31%
Dec 31, 2008	446.40M	-54.99%
Dec 31, 2007	991.70M	73.25%
Dec 29, 2006	572.40M	-16.56%
Dec 30, 2005	686.00M	19.85%
Dec 31, 2004	572.40M	38.03%
Dec 31, 2003	414.70M	-16.41%
Dec 31, 2002	496.10M	-18.92%
Dec 31, 2001	611.90M	0.02%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	696.15B
Johnson & Johnson	366.71B
AbbVie	322.03B
Novo Nordisk	304.96B
UnitedHealth Group	280.41B
Abbott Laboratories	233.80B
Novartis AG	227.75B
AstraZeneca	220.36B

Market Cap Rankings